Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in France next month following the successful resumption of product shipments.

Allurion Technologies Inc (NYSE:ALUR) achieved a first-quarter revenue of $5.6 million with a significant decrease in operating expenses by 45% compared to the previous year. The company reported ...

Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call Transcript May 14, 2025 Allurion Technologies Inc. beats earnings expectations. Reported EPS is $0.43, expectations were $-1.53.

A high-level overview of Allurion Technologies Inc. (ALUR) stock. View (ALUR) real-time stock price, chart, news, analysis, analyst reviews and more.

Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in France next month following the successful resumption of product shipments.

Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program. NATICK, Mass., May 27, 2025--Allurion Technologies, Inc. ("Allurion" or the ...

Release Date: May 14, 2025. For the complete transcript of the earnings call, please refer to the full earnings call transcript.. Positive Points. Allurion Technologies Inc achieved a first-quarter ...

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that Dr. Shantanu Gau ...

Review quarterly and annual revenue, net income, and cash flow for Allurion Technologies Inc (ALUR:XNYS) stock through the last fiscal year.

A high-level overview of Allurion Technologies Inc. WT EXP 080130 (ALUR.WS) stock. View (ALUR.WS) real-time stock price, chart, news, analysis, analyst reviews and more.